from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3256c/-

LFCtreatmentdescriptionclass of inhibitor

-1.189

Amikacinug/mL Amikacintranslation

-0.533

Cap5-10ug/mL Capreomycintranslation

-1.514

Rox10-50 ug/mL Roxithromycintranslation

-0.759

SM2-5 ug/mL Streptomycintranslation

-1.667

Tet5-10 ug/mL Tetracyclinetranslation

0.520

Rif0.2-5ug/mL Rifampicintranscription

0.308

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.180

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.606

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.988

CPZ10-50 ug/mL Chlorpromazinerespiration

1.302

Clofazimine10-13 ug/mL Clofaziminerespiration

0.419

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.209

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.678

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.168

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.387

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.380

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.335

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.736

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.994

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.307

KCN5-20 ug/mL Potassium cyaniderespiration

0.195

NaN30.2-2 mM Sodium aziderespiration

-0.871

Nigericin50 uM Nigericinrespiration

0.549

TRC10-150 ug/mL Triclosanrespiration

0.584

TRZ10-25 ug/mL Thioridazinerespiration

-1.538

Valinomycin0.5-10 uM Valinomycinrespiration

-0.157

ZnSO42 mM ZnSO4respiration

-0.807

menadione6-10 ug/mL Menadionerespiration

0.001

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.173

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.209

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.456

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.046

NRP_1Non-replicating persistence stage 1dosRassociated

0.232

Amp0.2mg/mL AmpicillincellWall

-0.033

Cephalexin20-100 ug/mL CephalexincellWall

-0.165

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.504

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.511

EMB10-20 ug/mL EthambutolcellWall

0.049

Eta12-40 ug/mL EthionamidecellWall

-0.121

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.415

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.470

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.644

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.851

BZA0.12 mg/mL BenzamidearomaticAmides

-0.640

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.103

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.467

H2O24 mM hydrogen peroxideDNAdamaging

-0.251

Levo10 ug/mL LevofloxacinDNAdamaging

-0.226

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.182

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.126

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.240

UVUV-irradiationDNAdamaging

-0.583

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.129

Antimycin12.5-50 ug/mL Antimycin A?

-0.220

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.189

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.039

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.212

PA8240.2-2 ug/mL PA-824?

1.494

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.712

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.337

Verapamil50 uM Verapamil?

-0.761

mercaptoethanol2 mM 2-Mercaptoethanol?

0.310

methoxatin10-20 ug/mL Methoxatin?